Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 19 entries
Sorted by: Best Match Show Resources per page
Dexamethasone Down-Regulates Expression of Triggering Receptor Expressed on Myeloid Cells-1: Evidence for a TNFα-Related Effect.

Frontiers in public health

Mihailidou I, Pelekanou A, Pistiki A, Spyridaki A, Tzepi IM, Damoraki G, Giamarellos-Bourboulis EJ.
PMID: 24350219
Front Public Health. 2013 Nov 14;1:50. doi: 10.3389/fpubh.2013.00050. eCollection 2013.

OBJECTIVES: To investigate the effect of dexamethasone on triggering receptor expressed on myeloid cells-1 (TREM-1).METHODS: Wild-type and tumor necrosis factor (TNF (-/-)) mice were pre-treated with saline, dexamethasone, or hydrocortisone and exposed to a lethal infection of Pseudomonas aeruginosa....

Cite
Mihailidou I, Pelekanou A, Pistiki A, et al. Dexamethasone Down-Regulates Expression of Triggering Receptor Expressed on Myeloid Cells-1: Evidence for a TNFα-Related Effect. Front Public Health. 2013;1:50doi: 10.3389/fpubh.2013.00050.
Mihailidou, I., Pelekanou, A., Pistiki, A., Spyridaki, A., Tzepi, I. M., Damoraki, G., & Giamarellos-Bourboulis, E. J. (2013). Dexamethasone Down-Regulates Expression of Triggering Receptor Expressed on Myeloid Cells-1: Evidence for a TNFα-Related Effect. Frontiers in public health, 150. https://doi.org/10.3389/fpubh.2013.00050
Mihailidou, Ira, et al. "Dexamethasone Down-Regulates Expression of Triggering Receptor Expressed on Myeloid Cells-1: Evidence for a TNFα-Related Effect." Frontiers in public health vol. 1 (2013): 50. doi: https://doi.org/10.3389/fpubh.2013.00050
Mihailidou I, Pelekanou A, Pistiki A, Spyridaki A, Tzepi IM, Damoraki G, Giamarellos-Bourboulis EJ. Dexamethasone Down-Regulates Expression of Triggering Receptor Expressed on Myeloid Cells-1: Evidence for a TNFα-Related Effect. Front Public Health. 2013 Nov 14;1:50. doi: 10.3389/fpubh.2013.00050. eCollection 2013. PMID: 24350219; PMCID: PMC3859977.
Copy Download .nbib Format: NLM
Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models.

Oncotarget

Mihailidou C, Papakotoulas P, Papavassiliou AG, Karamouzis MV.
PMID: 29535812
Oncotarget. 2017 Dec 08;9(12):10360-10374. doi: 10.18632/oncotarget.23164. eCollection 2018 Feb 13.

Ciclopirox olamine (CPX) is an antifungal agent that has recently demonstrated promising anti-neoplastic activity against hematologic and solid tumors. Here, we evaluated CPX compared with gemcitabine alone as well as their combination in human pancreatic cancer cell lines; BxPC-3,...

Cite
Mihailidou C, Papakotoulas P, Papavassiliou AG, et al. Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models. Oncotarget. 2017;9(12):10360-10374doi: 10.18632/oncotarget.23164.
Mihailidou, C., Papakotoulas, P., Papavassiliou, A. G., & Karamouzis, M. V. (2018). Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models. Oncotarget, 9(12), 10360-10374. https://doi.org/10.18632/oncotarget.23164
Mihailidou, Chrysovalantou, et al. "Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models." Oncotarget vol. 9,12 (2018): 10360-10374. doi: https://doi.org/10.18632/oncotarget.23164
Mihailidou C, Papakotoulas P, Papavassiliou AG, Karamouzis MV. Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models. Oncotarget. 2017 Dec 08;9(12):10360-10374. doi: 10.18632/oncotarget.23164. eCollection 2018 Feb 13. PMID: 29535812; PMCID: PMC5828195.
Copy Download .nbib Format: NLM
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030.

Lancet (London, England)

Vogel B, Acevedo M, Appelman Y, Bairey Merz CN, Chieffo A, Figtree GA, Guerrero M, Kunadian V, Lam CSP, Maas AHEM, Mihailidou AS, Olszanecka A, Poole JE, Saldarriaga C, Saw J, Zühlke L, Mehran R.
PMID: 34010613
Lancet. 2021 Jun 19;397(10292):2385-2438. doi: 10.1016/S0140-6736(21)00684-X. Epub 2021 May 16.

Cardiovascular disease is the leading cause of death in women. Decades of grassroots campaigns have helped to raise awareness about the impact of cardiovascular disease in women, and positive changes affecting women and their health have gained momentum. Despite...

Cite
Vogel B, Acevedo M, Appelman Y, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet. 2021;397(10292):2385-2438doi: 10.1016/S0140-6736(21)00684-X.
Vogel, B., Acevedo, M., Appelman, Y., Bairey Merz, C. N., Chieffo, A., Figtree, G. A., Guerrero, M., Kunadian, V., Lam, C. S. P., Maas, A. H. E. M., Mihailidou, A. S., Olszanecka, A., Poole, J. E., Saldarriaga, C., Saw, J., Zühlke, L., & Mehran, R. (2021). The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet (London, England), 397(10292), 2385-2438. https://doi.org/10.1016/S0140-6736(21)00684-X
Vogel, Birgit, et al. "The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030." Lancet (London, England) vol. 397,10292 (2021): 2385-2438. doi: https://doi.org/10.1016/S0140-6736(21)00684-X
Vogel B, Acevedo M, Appelman Y, Bairey Merz CN, Chieffo A, Figtree GA, Guerrero M, Kunadian V, Lam CSP, Maas AHEM, Mihailidou AS, Olszanecka A, Poole JE, Saldarriaga C, Saw J, Zühlke L, Mehran R. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet. 2021 Jun 19;397(10292):2385-2438. doi: 10.1016/S0140-6736(21)00684-X. Epub 2021 May 16. PMID: 34010613.
Copy Download .nbib Format: NLM
Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials.

Clinical journal of the American Society of Nephrology : CJASN

Shaman AM, Smyth B, Arnott C, Palmer SC, Mihailidou AS, Jardine MJ, Gallagher MP, Perkovic V, Jun M.
PMID: 32675281
Clin J Am Soc Nephrol. 2020 Aug 07;15(8):1129-1138. doi: 10.2215/CJN.12201019. Epub 2020 Jul 16.

BACKGROUND AND OBJECTIVES: Elevated BP is an important risk factor for cardiovascular disease, with a prevalence of over 80% in patients undergoing maintenance dialysis. We assessed the comparative BP-lowering efficacy and the safety of BP-lowering drugs in patients undergoing...

Cite
Shaman AM, Smyth B, Arnott C, et al. Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials. Clin J Am Soc Nephrol. 2020;15(8):1129-1138doi: 10.2215/CJN.12201019.
Shaman, A. M., Smyth, B., Arnott, C., Palmer, S. C., Mihailidou, A. S., Jardine, M. J., Gallagher, M. P., Perkovic, V., & Jun, M. (2020). Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials. Clinical journal of the American Society of Nephrology : CJASN, 15(8), 1129-1138. https://doi.org/10.2215/CJN.12201019
Shaman, Ahmed M, et al. "Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials." Clinical journal of the American Society of Nephrology : CJASN vol. 15,8 (2020): 1129-1138. doi: https://doi.org/10.2215/CJN.12201019
Shaman AM, Smyth B, Arnott C, Palmer SC, Mihailidou AS, Jardine MJ, Gallagher MP, Perkovic V, Jun M. Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials. Clin J Am Soc Nephrol. 2020 Aug 07;15(8):1129-1138. doi: 10.2215/CJN.12201019. Epub 2020 Jul 16. PMID: 32675281; PMCID: PMC7409758.
Copy Download .nbib Format: NLM
May Measurement Month 2017: an analysis of blood pressure screening results from Australia-South-East Asia and Australasia.

European heart journal supplements : journal of the European Society of Cardiology

Carnagarin R, Fonseca R, Brockman D, Hering D, Matthews VB, Mihailidou A, Reid C, Lee R, Lambert GW, Burrell LM, Sharman JE, Xia X, Poulter NR, Beaney T, Islam SM, Carrington M, Schlaich MP.
PMID: 31043866
Eur Heart J Suppl. 2019 Apr;21:D14-D16. doi: 10.1093/eurheartj/suz052. Epub 2019 Apr 24.

Increased blood pressure (BP) is the single biggest contributing risk factor to the global disease burden. May Measurement Month (MMM) is a global initiative of the International Society of Hypertension aimed at raising awareness of high BP. In Australia,...

Cite
Carnagarin R, Fonseca R, Brockman D, et al. May Measurement Month 2017: an analysis of blood pressure screening results from Australia-South-East Asia and Australasia. Eur Heart J Suppl. 2019;21:D14-D16doi: 10.1093/eurheartj/suz052.
Carnagarin, R., Fonseca, R., Brockman, D., Hering, D., Matthews, V. B., Mihailidou, A., Reid, C., Lee, R., Lambert, G. W., Burrell, L. M., Sharman, J. E., Xia, X., Poulter, N. R., Beaney, T., Islam, S. M., Carrington, M., & Schlaich, M. P. (2019). May Measurement Month 2017: an analysis of blood pressure screening results from Australia-South-East Asia and Australasia. European heart journal supplements : journal of the European Society of Cardiology, 21D14-D16. https://doi.org/10.1093/eurheartj/suz052
Carnagarin, Revathy, et al. "May Measurement Month 2017: an analysis of blood pressure screening results from Australia-South-East Asia and Australasia." European heart journal supplements : journal of the European Society of Cardiology vol. 21 (2019): D14-D16. doi: https://doi.org/10.1093/eurheartj/suz052
Carnagarin R, Fonseca R, Brockman D, Hering D, Matthews VB, Mihailidou A, Reid C, Lee R, Lambert GW, Burrell LM, Sharman JE, Xia X, Poulter NR, Beaney T, Islam SM, Carrington M, Schlaich MP. May Measurement Month 2017: an analysis of blood pressure screening results from Australia-South-East Asia and Australasia. Eur Heart J Suppl. 2019 Apr;21:D14-D16. doi: 10.1093/eurheartj/suz052. Epub 2019 Apr 24. PMID: 31043866; PMCID: PMC6479418.
Copy Download .nbib Format: NLM
Characterization of Artisanal Spontaneous Sourdough Wheat Bread from Central Greece: Evaluation of Physico-Chemical, Microbiological, and Sensory Properties in Relation to Conventional Yeast Leavened Wheat Bread.

Foods (Basel, Switzerland)

Katsi P, Kosma IS, Michailidou S, Argiriou A, Badeka AV, Kontominas MG.
PMID: 33802818
Foods. 2021 Mar 17;10(3). doi: 10.3390/foods10030635.

In the present study, both yeast leavened bread (YLB) and artisanal sourdough wheat bread (SDB) were prepared. The physico-chemical, microbiological, and sensory properties of breads were monitored as a function of storage time (T = 25 °C). As expected,...

Cite
Katsi P, Kosma IS, Michailidou S, et al. Characterization of Artisanal Spontaneous Sourdough Wheat Bread from Central Greece: Evaluation of Physico-Chemical, Microbiological, and Sensory Properties in Relation to Conventional Yeast Leavened Wheat Bread. Foods. 2021;10(3)doi: 10.3390/foods10030635.
Katsi, P., Kosma, I. S., Michailidou, S., Argiriou, A., Badeka, A. V., & Kontominas, M. G. (2021). Characterization of Artisanal Spontaneous Sourdough Wheat Bread from Central Greece: Evaluation of Physico-Chemical, Microbiological, and Sensory Properties in Relation to Conventional Yeast Leavened Wheat Bread. Foods (Basel, Switzerland), 10(3), . https://doi.org/10.3390/foods10030635
Katsi, Pavlina, et al. "Characterization of Artisanal Spontaneous Sourdough Wheat Bread from Central Greece: Evaluation of Physico-Chemical, Microbiological, and Sensory Properties in Relation to Conventional Yeast Leavened Wheat Bread." Foods (Basel, Switzerland) vol. 10,3 (2021). doi: https://doi.org/10.3390/foods10030635
Katsi P, Kosma IS, Michailidou S, Argiriou A, Badeka AV, Kontominas MG. Characterization of Artisanal Spontaneous Sourdough Wheat Bread from Central Greece: Evaluation of Physico-Chemical, Microbiological, and Sensory Properties in Relation to Conventional Yeast Leavened Wheat Bread. Foods. 2021 Mar 17;10(3). doi: 10.3390/foods10030635. PMID: 33802818; PMCID: PMC8002528.
Copy Download .nbib Format: NLM
Tuberculous otitis media with facial paralysis: a clinical and microbiological diagnosis-a case report.

Case reports in infectious diseases

Quaranta N, Petrone P, Michailidou A, Miragliotta L, Santantonio M, Del Prete R, Mosca A, Miragliotta G.
PMID: 22570801
Case Rep Infect Dis. 2011;2011:932608. doi: 10.1155/2011/932608. Epub 2011 Jul 02.

The tuberculosis of the ear is rare, and in most cases the clinical picture resembles that of a chronic otitis media. The diagnosis is often delayed, and this can lead to irreversible complications such as hearing loss and/or facial...

Cite
Quaranta N, Petrone P, Michailidou A, et al. Tuberculous otitis media with facial paralysis: a clinical and microbiological diagnosis-a case report. Case Rep Infect Dis. 2011;2011:932608doi: 10.1155/2011/932608.
Quaranta, N., Petrone, P., Michailidou, A., Miragliotta, L., Santantonio, M., Del Prete, R., Mosca, A., & Miragliotta, G. (2011). Tuberculous otitis media with facial paralysis: a clinical and microbiological diagnosis-a case report. Case reports in infectious diseases, 2011932608. https://doi.org/10.1155/2011/932608
Quaranta, Nicola, et al. "Tuberculous otitis media with facial paralysis: a clinical and microbiological diagnosis-a case report." Case reports in infectious diseases vol. 2011 (2011): 932608. doi: https://doi.org/10.1155/2011/932608
Quaranta N, Petrone P, Michailidou A, Miragliotta L, Santantonio M, Del Prete R, Mosca A, Miragliotta G. Tuberculous otitis media with facial paralysis: a clinical and microbiological diagnosis-a case report. Case Rep Infect Dis. 2011;2011:932608. doi: 10.1155/2011/932608. Epub 2011 Jul 02. PMID: 22570801; PMCID: PMC3336232.
Copy Download .nbib Format: NLM
Amplicon metabarcoding data of prokaryotes and eukaryotes present in 'Kalamata' table olives packaged under modified atmosphere.

Data in brief

Michailidou S, Petrovits GE, Kyritsi M, Argiriou A.
PMID: 34485644
Data Brief. 2021 Aug 20;38:107314. doi: 10.1016/j.dib.2021.107314. eCollection 2021 Oct.

Evaluation of food microbiome is of major importance since it accounts for the product's organoleptic characteristics and their nutritional value. In this dataset, microbes present in olive samples ('Kalamata' variety) stored under modified atmosphere and throughout different time-points of...

Cite
Michailidou S, Petrovits GE, Kyritsi M, et al. Amplicon metabarcoding data of prokaryotes and eukaryotes present in 'Kalamata' table olives packaged under modified atmosphere. Data Brief. 2021;38:107314doi: 10.1016/j.dib.2021.107314.
Michailidou, S., Petrovits, G. E., Kyritsi, M., & Argiriou, A. (2021). Amplicon metabarcoding data of prokaryotes and eukaryotes present in 'Kalamata' table olives packaged under modified atmosphere. Data in brief, 38107314. https://doi.org/10.1016/j.dib.2021.107314
Michailidou, Sofia, et al. "Amplicon metabarcoding data of prokaryotes and eukaryotes present in 'Kalamata' table olives packaged under modified atmosphere." Data in brief vol. 38 (2021): 107314. doi: https://doi.org/10.1016/j.dib.2021.107314
Michailidou S, Petrovits GE, Kyritsi M, Argiriou A. Amplicon metabarcoding data of prokaryotes and eukaryotes present in 'Kalamata' table olives packaged under modified atmosphere. Data Brief. 2021 Aug 20;38:107314. doi: 10.1016/j.dib.2021.107314. eCollection 2021 Oct. PMID: 34485644; PMCID: PMC8397911.
Copy Download .nbib Format: NLM
Comparative Transcriptome Analysis of Milk Somatic Cells During Lactation Between Two Intensively Reared Dairy Sheep Breeds.

Frontiers in genetics

Michailidou S, Gelasakis A, Banos G, Arsenos G, Argiriou A.
PMID: 34349787
Front Genet. 2021 Jul 19;12:700489. doi: 10.3389/fgene.2021.700489. eCollection 2021.

In dairy sheep industry, milk production dictates the value of a ewe. Milk production is directly related to the morphology and physiology of the mammary gland; both being designated targets of breeding strategies. Although within a flock breeding parameters...

Cite
Michailidou S, Gelasakis A, Banos G, et al. Comparative Transcriptome Analysis of Milk Somatic Cells During Lactation Between Two Intensively Reared Dairy Sheep Breeds. Front Genet. 2021;12:700489doi: 10.3389/fgene.2021.700489.
Michailidou, S., Gelasakis, A., Banos, G., Arsenos, G., & Argiriou, A. (2021). Comparative Transcriptome Analysis of Milk Somatic Cells During Lactation Between Two Intensively Reared Dairy Sheep Breeds. Frontiers in genetics, 12700489. https://doi.org/10.3389/fgene.2021.700489
Michailidou, Sofia, et al. "Comparative Transcriptome Analysis of Milk Somatic Cells During Lactation Between Two Intensively Reared Dairy Sheep Breeds." Frontiers in genetics vol. 12 (2021): 700489. doi: https://doi.org/10.3389/fgene.2021.700489
Michailidou S, Gelasakis A, Banos G, Arsenos G, Argiriou A. Comparative Transcriptome Analysis of Milk Somatic Cells During Lactation Between Two Intensively Reared Dairy Sheep Breeds. Front Genet. 2021 Jul 19;12:700489. doi: 10.3389/fgene.2021.700489. eCollection 2021. PMID: 34349787; PMCID: PMC8326974.
Copy Download .nbib Format: NLM
Impact of hypertensive disorders of pregnancy: lessons from CONCEPTION.

European heart journal

Mihailidou AS, Gulati M.
PMID: 34661641
Eur Heart J. 2021 Oct 18; doi: 10.1093/eurheartj/ehab666. Epub 2021 Oct 18.

No abstract available.

Cite
Mihailidou AS, Gulati M. Impact of hypertensive disorders of pregnancy: lessons from CONCEPTION. Eur Heart J. 2021;doi: 10.1093/eurheartj/ehab666.
Mihailidou, A. S., & Gulati, M. (2021). Impact of hypertensive disorders of pregnancy: lessons from CONCEPTION. European heart journal, . https://doi.org/10.1093/eurheartj/ehab666
Mihailidou, Anastasia S, and Gulati, Martha. "Impact of hypertensive disorders of pregnancy: lessons from CONCEPTION." European heart journal vol. (2021). doi: https://doi.org/10.1093/eurheartj/ehab666
Mihailidou AS, Gulati M. Impact of hypertensive disorders of pregnancy: lessons from CONCEPTION. Eur Heart J. 2021 Oct 18; doi: 10.1093/eurheartj/ehab666. Epub 2021 Oct 18. PMID: 34661641.
Copy Download .nbib Format: NLM
Polyomyositis and myocarditis associated with acquired toxoplasmosis in an immunocompetent girl.

BMC musculoskeletal disorders

Paspalaki PK, Mihailidou EP, Bitsori M, Tsagkaraki D, Mantzouranis E.
PMID: 11818029
BMC Musculoskelet Disord. 2001;2:8. doi: 10.1186/1471-2474-2-8. Epub 2001 Nov 20.

BACKGROUND: Acquired toxoplasmosis more frequently goes unrecognized. Immunocompetent adults and adolescents with primary infection are generally asymptomatic, but symptoms may include malaise, fever, and lymphadenopathy. By contrast, immunocompromised patients may experience severe manifestations including encephalitis and multisystem organ failure.CASE...

Cite
Paspalaki PK, Mihailidou EP, Bitsori M, et al. Polyomyositis and myocarditis associated with acquired toxoplasmosis in an immunocompetent girl. BMC Musculoskelet Disord. 2001;2:8doi: 10.1186/1471-2474-2-8.
Paspalaki, P. K., Mihailidou, E. P., Bitsori, M., Tsagkaraki, D., & Mantzouranis, E. (2001). Polyomyositis and myocarditis associated with acquired toxoplasmosis in an immunocompetent girl. BMC musculoskeletal disorders, 28. https://doi.org/10.1186/1471-2474-2-8
Paspalaki, P K, et al. "Polyomyositis and myocarditis associated with acquired toxoplasmosis in an immunocompetent girl." BMC musculoskeletal disorders vol. 2 (2001): 8. doi: https://doi.org/10.1186/1471-2474-2-8
Paspalaki PK, Mihailidou EP, Bitsori M, Tsagkaraki D, Mantzouranis E. Polyomyositis and myocarditis associated with acquired toxoplasmosis in an immunocompetent girl. BMC Musculoskelet Disord. 2001;2:8. doi: 10.1186/1471-2474-2-8. Epub 2001 Nov 20. PMID: 11818029; PMCID: PMC65052.
Copy Download .nbib Format: NLM
Unexpected supraglottic injury following a frontal impact motor-vehicle accident.

BMJ case reports

Briassoulis G, Fitrolaki MD, Mihailidou E, Spanaki AM.
PMID: 21687320
BMJ Case Rep. 2009;2009:bcr2008137380. doi: 10.1136/bcr.2008.137380. Epub 2009 Jan 08.

No abstract available.

Cite
Briassoulis G, Fitrolaki MD, Mihailidou E, et al. Unexpected supraglottic injury following a frontal impact motor-vehicle accident. BMJ Case Rep. 2009;2009:bcr2008137380doi: 10.1136/bcr.2008.137380.
Briassoulis, G., Fitrolaki, M. D., Mihailidou, E., & Spanaki, A. M. (2009). Unexpected supraglottic injury following a frontal impact motor-vehicle accident. BMJ case reports, 2009bcr2008137380. https://doi.org/10.1136/bcr.2008.137380
Briassoulis, G, et al. "Unexpected supraglottic injury following a frontal impact motor-vehicle accident." BMJ case reports vol. 2009 (2009): bcr2008137380. doi: https://doi.org/10.1136/bcr.2008.137380
Briassoulis G, Fitrolaki MD, Mihailidou E, Spanaki AM. Unexpected supraglottic injury following a frontal impact motor-vehicle accident. BMJ Case Rep. 2009;2009:bcr2008137380. doi: 10.1136/bcr.2008.137380. Epub 2009 Jan 08. PMID: 21687320; PMCID: PMC3034800.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 19 entries